Your Messages Inbox
Your Article Summary
See Latest ArticlesNew Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Corporate News Releases - The Healthcare Sales & Marketing Network, 09/08/08
The Medicines Company announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/17/09
Trends in hypertension treatment in diabetes
Current Hypertension Reports, 12/09/09
New program helps educate survivors of a heart event about the importance of maintaining good physical and emotional health
Daiichi Sankyo, 12/08/09
Article Search
Sponsor